Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LipoTherapeia Cellulite Clinic Introduces Celluence® Creams To Relieve Heavy, Tired Legs This Summer
  • USA - English


News provided by

LipoTherapeia

Jun 14, 2016, 09:30 ET

Share this article

Share toX

Share this article

Share toX

Celluence® Phase One | Advanced leg wellness cream
Celluence® Phase One | Advanced leg wellness cream

Los Angeles, California (PRWEB) June 14, 2016 -- LipoTherapeia, the London, UK cellulite clinic, launches the Celluence® cellulite creams for instant refreshment for tired, heavy legs this summer with an impressive line up of forty natural actives, specific to leg wellness and cellulite.

Upon application, the cream leaves a nice, lasting refreshing sensation - a feel that "it's working" - and gets absorbed quickly

Post this

The Celluence® creams are unique in that they contain not one or two but forty natural actives in high concentrations - in contrast to any other cellulite cream. These actives are very well researched for their action on all seven aspects of cellulite: circulation, superficial fat accumulation, skin laxity, fibrosis, glycation, oxidative damage and low grade inflammation.

As most of the factors that cause cellulite also affect the well-being of the thighs and lower legs, application of the creams also provides instant refreshment for legs suffering from water retention, poor circulation, heaviness, tiredness and “restless legs”.

The Celluence® creams contain an impressive collection of all the widely researched natural actives, comprising caffeine, curcumin, forskolin, escin, pine bark extract, vitamin C, gotu kola/centella asiatica, butcher’s broom extract, hesperidin, carnosine, rutin, hydroxyproline and 28 more actives.

The creams are especially useful in the heat of the summer, after a long day standing up or sitting in the office or for long haul flights. The mint, lemon and mandarin essential oils contained in the cream are said to offer a soothing feeling of freshness, lightness and wellness within minutes, as customer testimonies describe:

  • “It makes your legs feel alive and far lighter than they have done all day. While the swelling may not all have gone completely away, any pain that was in the legs has certainly calmed and the legs feel rested and refreshed. The Phase One and Two creams give a wonderfully light, mobile and and energetic feeling to tired legs.”
  • “You feel the cream working immediately as it creates a tingling sensation on your skin and beneath your skin. I feel it penetrating my skin targeting my unwanted fat.”
  • “I decided to invest in both creams (Phase One and Phase Two) and it is the best decision I have made, not only for the toning up of the ripples and dimples but also for the improved circulation and feel of well-being in my legs in general.”
  • “Upon application, the creams leave a nice, lasting refreshing sensation (a feel that "it's working") and get absorbed quickly. After 2-3 months my skin looked better, it was more firm and toned. I think these creams are among the best cellulite creams you can get and good value for money considering the high number of active ingredients they contain. I would definitely recommend them!"

The Celluence® creams were formulated by Georgios Tzenichristos, cellulite expert and director of LipoTherapeia, London’s only aesthetic practice dedicated to cellulite and skin tightening. “Formulating the Celluence® creams was an enormous project, as we set to the task of poring over 400 different actives that could be used for cellulite and overall leg wellness. Out of those 400 actives we shortlisted 160 of them to test in the lab, arriving at the eclectic mix of 40 natural actives that are used in our creams”.

Georgios goes on to add that: “We do not claim to eliminate cellulite or to “cure” anything, including leg heaviness, but we are proud to offer the most comprehensive and concentrated anti-cellulite / leg creams on the market today. There are literally hundreds of studies on those actives - and the results of using the creams speak for themselves, both in terms of cellulite and leg wellness: we have great customer satisfaction, a high repeat order rate, almost zero return rate for our creams, and plenty of positive testimonies.”

The Celluence® creams are used twice a day, morning and night. They are fully absorbed within five minutes and they offer an invigorating feeling of freshness and "feel good" factor upon application. Repeated application over a period of 1-3 months will offer the best results for cellulite, in combination, of course, with a healthy diet and exercise regime.

As the Celluence® creams are very concentrated—comprising a long, expensive list of actives—they are only offered direct from LipoTherapeia, so customers pay for natural actives instead of retail markups and distribution costs. The creams cost GBP95 each or GBP135 for both (currently USD138 and USD196, respectively), and they can be ordered with tracked worldwide delivery at http://www.lipotherapeia.com/the-celluence-store (free delivery to the US, Canada and Australia).

For more information on the Celluence® creams, and for journalist enquiries, please visit http://www.lipotherapeia.com/celluence, call LipoTherapeia on +44 20 7118 2014 or email them at http://www.lipotherapeia.com/contact.

Disclaimer: This information and the Celluence® creams is not intended to replace, or be used as, medical advice or treatment for any condition. Results vary from person to person.

Georgios Tzenichristos, LipoTherapeia, http://www.lipotherapeia.com, +44 2071182014, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.